Cyclophosphamide (generic), Cytoxan

Cyclophosphamide (generic), Cytoxan Newswire

Comprehensive Real-Time News Feed for Cyclophosphamide (generic), Cytoxan.

Results 1 - 20 of 194 in Cyclophosphamide (generic), Cytoxan

  1. What is new in the management of rapidly progressive glomerulonephritis?Read the original story

    12 hrs ago | CiteULike

    Rapidly progressive glomerulonephritis results from severe crescentic damage to glomeruli and leads to irreversible kidney failure if not diagnosed and managed in a timely fashion. Traditional treatment has relied on glucocorticoids and cyclophosphamide, with additional plasmapheresis for certain conditions.

    Comment?

  2. Canadian Pharmacy Announces the Generic Cancer Drugs ProgramRead the original story w/Photo

    Thursday | 24-7 Press Release

    NationDrugs.com announces that cancer patients now have more access to more affordable medications through its International Generics Program MONTREAL, QC, March 27, 2015 /24-7PressRelease/ -- NationDrugs.com the premier Canadian pharmacy intermediary since 2002 highlights the need to help cancer patients find access to more affordable cancer medications. The Wall Street Journal featured an article in February 2015 about Hagop Kantarjian discussing his concern for the affordability of cancer drugs.

    Comment?

  3. New treatment for mantle cell lymphoma (MCL) now available for patients in the UKRead the original story

    Wednesday Mar 25 | Medical News Today

    VELCADE has been approved today in the UK for the first-line treatment of Mantle Cell Lymphoma , an aggressive subtype of blood cancers , collectively known as Non-Hodgkin Lymphoma . Recent clinical trial results have shown that patients with previously untreated MCL, who were unsuitable for blood stem-cell transplantation, had an improvement in progression free survival compared to the control arm when treated with bortezomib in combination with rituximab, cyclophosphamide, doxorubicin and prednisone .

    Comment?

  4. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.Read the original story

    Tuesday Mar 24 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. The combination of cyclophosphamide and glucocorticoids leads to remission in most patients with antineutrophil cytoplasm antibody -associated vasculitides.

    Comment?

  5. Which dose of steroids and which cytotoxics for severe lupus?Read the original story

    Tuesday Mar 24 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. There have been a number of major advances in the treatment of systemic lupus erythematosus and we are now in the era of biologic therapies for this multisystem autoimmune disorder.

    Comment?

  6. Getting the balance right: adverse events of therapy in...Read the original story

    Monday Mar 23 | CiteULike

    Antineutrophil cytoplasm antibody associated systemic vasculitides have traditionally been managed with a combination of cyclophosphamide and glucocorticoids during the induction phase, followed by azathioprine in the maintenance phase. Whilst these therapies have markedly improved the prognosis in AASV, treatment related adverse events remain a major challenge and include complications such as infection, glucocorticoid related side effects, malignancy, cardiovascular disease, infertility and death.

    Comment?

  7. Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis.Read the original story

    Monday Mar 23 | CiteULike

    Despite major advances in the management of anti-neutrophil cytoplasmic antibody -associated vasculitides achieved in the last decades, a large proportion of AAV patients still develop end-stage renal disease. The survival of AAV patients dependent on dialysis is significantly worse compared with dialysis-independent AAV patients, but is comparable to other non-diabetic patients requiring dialysis.

    Comment?

  8. B-cell therapy in antineutrophil cytoplasmic antibody-associated vasculitis.Read the original story

    Monday Mar 23 | CiteULike

    Until recently, standard of care for patients with generalized or severe antineutrophil cytoplasmic antibody -associated vasculitis has consisted of an induction regimen with cyclophosphamide and corticosteroids followed by maintenance treatment with azathioprine. This regimen is associated with significant toxicity resulting in considerable morbidity and mortality whereas relapses are still not infrequent.

    Comment?

  9. Maintenance therapy in antineutrophil cytoplasmic antibody-associated ...Read the original story

    Monday Mar 23 | CiteULike

    Anti-neutrophil cytoplasmic autoantibody -associated vasculitides are severe chronic auto-immune diseases in which the small vessels are inflamed. Nowadays, in the majority of patients disease can be brought into remission with cyclophosphamide and corticosteroids.

    Comment?

  10. Exercise slows tumor growth, improves chemotherapy in mouse cancersRead the original story w/Photo

    Monday Mar 16 | Science Daily

    One way many cancers grow resistant to treatment is by generating a web of blood vessels that are so jumbled they fail to provide adequate oxygen to the tumor. With oxygen starvation, the tumor gains a sort of cloaking device that protects it from the toxic effects of chemotherapy drugs and radiation, which are designed to seek out well-oxygenated tissue.

    Comment?

  11. Immunovaccine Announces 2014 Year-End ResultsRead the original story w/Photo

    Friday Mar 20 | Market Wire

    Immunovaccine Inc. , a clinical stage vaccine company, today announced its financial and operational results for the year ended December 31, 2014. "During 2014, we continued to broaden awareness in the scientific and investor communities of the potential of our novel DepoVax platform, in both cancer and infectious diseases.

    Comment?

  12. Exercise affects tumor growth and drug response in a mouse model of breast cancerRead the original story

    Wednesday Mar 18 | Medical News Today

    Abnormal growth of blood vessels in solid tumors creates areas of hypoxia, which, in turn makes the tumors more aggressive and resistant to therapy. Exercise has been shown to improve blood vessel growth and perfusion of normal tissues and may have the same effect in solid tumors, according to a study published in the JNCI: Journal of the National Cancer Institute.

    Comment?

  13. Exercise pumps up effectiveness of breast cancer therapy, study findsRead the original story w/Photo

    Monday Mar 16 | The Baltimore Sun

    A new treatment for breast cancer? A study in rodents suggests that exercise may slow tumor growth and increase the effectiveness of chemotherapy in breast cancer treatment. A new treatment for breast cancer? A study in rodents suggests that exercise may slow tumor growth and increase the effectiveness of chemotherapy in breast cancer treatment.

    Comment?

  14. InSphero Publication Honored for Potential to Reduce Use of Research AnimalsRead the original story

    Tuesday Mar 17 | PRWeb

    Multi-tissue in vitro test systems hold promise in the drug development industry as a better means of predicting the safety and efficacy of novel agents, while reducing the dependency on using animals for such studies Research conducted by InSphero AG, the world's leading supplier of 3D microtissues for in vitro safety and efficacy testing, and collaborators at ETH Zurich has received the "highly commended" honor from the British National Center for the Replacement, Refinement and Reduction of Animals in Research . Dr. Olivier Frey of ETH Zurich, first author on the paper published last June in the journal Nature Communications, accepted the award at the 3Rs Prize ceremony held last week in London.

    Comment?

  15. Researchers find that exercise may slow tumor growth, improve chemotherapyRead the original story w/Photo

    Tuesday Mar 17 | Medical News

    One way many cancers grow resistant to treatment is by generating a web of blood vessels that are so jumbled they fail to provide adequate oxygen to the tumor. With oxygen starvation, the tumor gains a sort of cloaking device that protects it from the toxic effects of chemotherapy drugs and radiation, which are designed to seek out well-oxygenated tissue.

    Comment?

  16. Aerobic exercise fights breast tumors, study in mice suggests - Tue, 17 Mar 2015 PSTRead the original story w/Photo

    Tuesday Mar 17 | The Spokesman-Review

    Aerobic exercise is no friend to breast tumors, says a new study that suggests that regular physical activity may be a "novel adjuvant treatment" for women with breast cancer. New research conducted on mice found that a body that gets regular physical activity is a more hostile environment for cancer's growth in breast tissue than is a sedentary body.

    Comment?

  17. Exercise slows tumor growth, improves chemotherapy in mouse cancersRead the original story w/Photo

    Monday Mar 16 | Science Blog

    One way many cancers grow resistant to treatment is by generating a web of blood vessels that are so jumbled they fail to provide adequate oxygen to the tumor. With oxygen starvation, the tumor gains a sort of cloaking device that protects it from the toxic effects of chemotherapy drugs and radiation, which are designed to seek out well-oxygenated tissue.

    Comment?

  18. Exercise affects tumor growth and drug response in a mouse model of breast cancerRead the original story w/Photo

    Sunday Mar 15 | EurekAlert!

    Abnormal growth of blood vessels in solid tumors creates areas of hypoxia, which, in turn makes the tumors more aggressive and resistant to therapy. Exercise has been shown to improve blood vessel growth and perfusion of normal tissues and may have the same effect in solid tumors, according to a study published March 16 in the JNCI: Journal of the National Cancer Institute .

    Comment?

  19. Curcumin proved effective at combating cancerRead the original story w/Photo

    Monday Mar 16 | PhysOrg Weblog

    WA scientists have helped re-affirm that curcumin, a chemical compound found in turmeric, is a safe and promising treatment for most cancers and other inflammation-driven diseases. The international review considered past clinical trials using curcumin to treat cancer patients and concluded curcumin was a safe and effective molecule to treat cancer.

    Comment?

  20. CROI 2015: We May Need to Combine Many Approaches to Achieve a Cure for HIVRead the original story w/Photo

    Friday Mar 13 | HIV and Hepatitis

    It is unlikely that one single approach will achieve a cure for HIV infection, according to research presenting at a community cure workshop held the day before the recent 2015 Conference on Retroviruses and Opportunistic Infections in Seattle. One approach was to seek ways to replace the body's immune cells with ones resistant to HIV infection.

    Comment?